Archive for the ‘Treatment’ Category

Full Body Numbness & Tingling Due to Lyme Disease

https://danielcameronmd.com/full-body-numbness-and-tingling-due-to-lyme-disease/

FULL BODY NUMBNESS AND TINGLING DUE TO LYME DISEASE

numbness-lyme-disease

In their article “Lyme Disease Presenting With Interesting Neurological Features of Weakness and Hyporeflexia: A Case Report,” Semy and colleagues describe the unique case of a young woman with Lyme disease who exhibited solely neurologic features of numbness and tingling throughout her body. [1]

By 

The 25-year-old female developed numbness and tingling throughout her torso, which later spread to her entire body. She presented to a neurology clinic with complaints of numbness and tingling that had been ongoing for the past 4 weeks.

She did not recall a rash or tick bite and had not recently travelled.

The woman did not exhibit any of the typical symptoms seen with Lyme disease such as “arthralgia, fever, rash, or regional lymphadenopathy but in fact exhibited decreased reflexes, numbness, and tingling particularly near the hypogastric region making it distinct from the classical presentation,” the authors wrote.

The numbness and tingling began on the right side of her stomach and radiated to her back and later spread to her entire body. “The tingling was not associated with any burning or pins and needle sensation,” the authors point out.

The woman was prescribed steroids and an albuterol inhaler. But her symptoms did not improve.

“She especially became alarmed when she could not hold her toddler anymore and ended up dropping the child secondary to her numbness and tingling.”

Motor examination revealed that the patient had “decreased tone more significant in the upper limbs (3/5) than in the lower limbs (4/5) along with hyporeflexia in the biceps, triceps, patellar, and Achilles,” the authors wrote.

A lumbar puncture revealed elevated protein concentration (148 mg/dl; normal: 15-60 mg/dl).

The Western blot test for Lyme disease was positive, and the woman was prescribed IV ceftriaxone for 3 days before transitioning to oral doxycycline.

“At the time of discharge, the patient was able to move all extremities spontaneously and ambulate with a normal gait,” the authors wrote. At her follow-up visit, she exhibited only minimal residuary weakness.

Authors’ Conclude:

  • “Physicians need to be aware of the non-pathognomonic timeline of the disease at presentation since the clinical presentation of the disease can differ significantly from one individual to another.”
Related Articles:

Atypical symptoms of Lyme disease: numbness, paresthesias and abdominal wall weakness

Small fiber neuropathy in Lyme disease and COVID-19

Neurologic complications of Babesia

References:
  1. Semy M, Lee-Kwen P, Semy S (August 10, 2023) Lyme Disease Presenting With Interesting Neurological Features of Weakness and Hyporeflexia: A Case Report. Cureus 15(8): e43296. doi:10.7759/cureus.43296

_______________

**Comment**

This woman needs long-term follow-up.  I wouldn’t be shocked at all if these symptoms came roaring back, which of course would necessitate treatment that our corrupt government states is “dangerous,” even though the alternative is deadly.

For more:

Category:

Lyme, research, Treatment

New Brunswick Pharmacists Can Now Access Funds to Treat “High-Risk” Tick Bites

https://www2.gnb.ca/content/gnb/en/news/news_release.2023.10.0498.html

Pharmacists now able to treat another common ailment

03 October 2023

FREDERICTON (GNB) – The provincial government is adding to the list of common ailments that pharmacists are publicly funded to treat, as part of an effort to give New Brunswickers better access to care. Starting today, pharmacists are funded to treat conjunctivitis, sometimes referred to as “pink eye.” This follows an announcement in May that residents could access publicly funded care from participating pharmacies for the following conditions: contact allergic dermatitis; cold sores; mild to moderate eczema; gastroesophageal reflux disease; impetigo; Lyme disease prevention after a high-risk tick bite; and mild acne. The Department of Health estimates 1,100 patients visited a walk-in clinic for conjunctivitis in the past year. “We know that many families are affected by conjunctivitis, and they need to see someone for relief,” said Health Minister Bruce Fitch. “To ensure that New Brunswickers can see the right care provider for the right service at the right time, we are working with our highly skilled pharmacists, who care for people in their communities, to make it easier to access these needed services.” Pharmacists in Quebec, Ontario and Saskatchewan are already able to treat conjunctivitis. New Brunswick pharmacists are now able to assess and prescribe for 12 common ailments and services to divert patient traffic from emergency rooms, walk-in clinics or other primary care providers. More information about publicly funded services that pharmacists can offer is available online. People are advised to ask their local pharmacist which services are available, as it is not mandatory for every pharmacist to treat all minor ailments. While the cost of the consultation for certain ailments is covered, patients are still responsible for the cost of prescribed medications, as well as any fees for injections provided by pharmacy professionals. 

______________

**Comment**

IMO this press release opens a big can of worms.

What is a high-risk tick bite?

Similarly to the mythology that there is some sort of “grace period” for tick bites, every tick bite I’m aware of has the potential to be highly risky in that you could become infected with one or more pathogens that could drop you to your knees in agony and deplete you of all your money and joy.  

The fact they are listing Lyme disease, pink eye, eczema, impetigo and gastric reflux in the same sentence shows this is still not being taken seriously.  

The article admits that Lyme disease is a “common” ailment, but gives far more weight to pink eye!

These pharmacists are not receiving any education, just money – which means they will not be informed about what they are doing.  While the press release doesn’t state what this “treatment” looks like, I’m going to venture a guess that they will prescribe one or two pills of doxycycline, which research has shown to be ineffective in preventing Lyme disease. 

In short: more garbage in, more garbage out.

COVID has given pharmacists more power in that they are now allowed to give “vaccines.”  Pharmacists are not doctors and do not have a patient’s medical history in front of them.  Nothing replaces one on one interaction between a patient and a doctor where a doctor is privy to a patient’s history.

This “Lyme treatment” bandaid will do little to relieve patient suffering.

For more:

 

Category:

Activism, Lyme, Ticks, Treatment

The Truth About COVID Hospital Protocols

https://www.theepochtimes.com/epochtv/the-truth-about-covid-hospital-protocols-stella-paul-  Video Here (Approx. 50 Min)

The Truth About COVID Hospital Protocols: Stella Paul

Oct. 17, 2023

During the COVID-19 pandemic, “patients lost all rights when they went in the hospital,” says Sen. Ron Johnson (R-Wis.) in the documentary “Making a Killing.” “They became prisoners.”
In this episode, we sit down with Stella Paul, a medical writer who has been investigating what she describes as “deadly” hospital protocols during the pandemic—and the financial incentives behind them.
“There were huge bonuses on what they were paid by the government if they used Remdesivir and if they ventilated—and both of those treatments are extremely dangerous,” Ms. Paul says.
In this episode, she breaks down what she and others have uncovered.
Go to link for video and full transcript.
_____________
For more:

Category:

Activism, Treatment, Viruses

The Dark History of SSRIs

**UPDATE**

Please see this 17 minute video by The Highwire on new science showing long term issues even after discontinuing SSRIs including sexual dysfunction and ‘brain zaps.’ Despite this, ‘the powers that be’ want to make these dangerous drugs over-the-counter.  

https://www.midwesterndoctor.com/p/there-is-decades-of-evidence-that?

The Decades of Evidence That SSRI Antidepressants Cause Mass Shootings

How Dangerous Must a Drug Be Before it is Pulled from the Market?

A MIDWESTERN DOCTOR
NOV 3, 2023

Most holistic doctors consider Selective Serotonin Reuptake Inhibitors (SSRI) anti-depressants to be one of most harmful mass-prescribed drugs on the market (it typically makes their top 5). However unlike the other drugs, which are just unsafe and ineffective, SSRIs also have a fairly unique problem—they can kill people who are not even taking the drugs.

Note: other common contenders for that list are Statins, NSAIDs (e.g., ibuprofen), and acid reflux medications (proton pump inhibitors like prilosec). The harms and irrationality of those drugs are discussed here, here and here.

What follows is a revised and updated article summarizing the extreme dangers of those drugs I was requested by a few readers to write in light of recent tragic events.  (See link for article)

______________

**Comment**

This is one of the most important articles I’ve read for a long time.  The reason?  The topic of harm caused by anti-depressants is completely denied and ignored by Big Pharma, Big Media, and Big Medicine. I highly recommend you read this in full and share widely because it affects so many people, particularly Lyme/MSIDS patients who often struggle with psychiatric symptoms including depression.  Educating yourself on this is imperative if not for you than for someone you know.

Executive Summary:

  • While a minority of patients, particularly those with deficient methylation, who take SSRIs greatly benefit from them, much evidence has accumulated that they cause psychotic violence.
  • The author states that out of all of the controversial medical issues, the topic of SSRIs being linked to mass shootings has caused the most vitriol.
  • Unfortunately, like COVID and “vaccines” SSRIs have been highly politicalized, often among party lines.
  • Each time a mass shooting occurs the same script is repeated (ban all guns and have more mental health care [i.e. psych meds] for everyone).
  • Similarly to the “vaccine” topic, the oft repeated argument to dismiss the link between SSRIs and psychotic violence is that “correlation is not causation,” however:
    • clinical trial data hidden from the public gives this evidence
    • a black-box warning states SSRIs increase the risk of suicide
    • the psychotic events are completely out of character and the offenders report a very similar narrative of what they experienced prior to and during the shooting
  • SSRIs which entered the market in 1988 have a similar primary mechanism of action as cocaine
  • The SSRI Prozac received nearly 40,000 adverse events after 9 years which is far more than any other drug. These events include:
    • hundreds of suicides
    • atrocious violent crimes
    • hostility and aggression
    • psychosis, confusion
    • distorted thinking
    • convulsions
    • amnesia
    • brain-zaps
    • long-term or permanent sexual dysfunction
    • homicides: a website has compiled thousands of documented occurrences
  • A significant portion of the article came from the book Deadly Psychiatry and Organized Denial by Peter C. Gøtzsche (which builds upon the critical work Peter Breggin did to expose this issue)
  • For those taking SSRIs, do NOT suddenly stop taking them as you can have very strong withdrawal symptoms.  Please read the stories in the article to see how very serious this is.
  • Psychosis and Akathisia (extreme restlessness) are known side-effects of SSRIs that have led to strange impulses, or suicide, homicide, or both and are so disturbing they are often described as the individual being possessed, and patients have shared they felt as though a dark force was trying to take over their body
  • A clinical investigator wrote to Pfizer that during treatment with SSRIs, patients reported depersonalization and that their range of emotions were blunted as they were unable to feel or express themselves.  Pfizer responded with the admission that this happens with SSRIs and nobody knows why.
  • A common thread has occurred with these violent homicides:
    • the act of violence was immediately preceded by a significant change in the meds 
    • they occur in all ages who were completely normal before the act and no precipitating factors besides the psychiatric medication
    • there were clear symptoms of akathisia
    • the offenders returned to their normal personality when they came off the antidepressant
  • Similarly to the “vaccine” industry, the psychiatric industry aggressively gaslights victims rather than accept any responsibility
  • Individuals with a mutation in the gene that metabolizes psych drugs are much more vulnerable to developing excessive levels of these drugs triggering psychosis and akathisia but this is never considered when the meds are prescribed
  • Gøtzsche reviewed some key SSRI legal cases and in 2001 a jury found a pharmaceutical firm liable for deaths caused by an antidepressant. Central to a case were SmithKline Beecham internal documents showing the company was aware that a small number of people could become agitated or violent from Paxil, but they did not include a package warning about suicide, violence or aggression.  Two volunteers attempted suicide, but the company till denies that Paxil can cause homicides, suicides, and withdrawals.
  • Similarly to the false illusion that remdesivir helps COVID and that the COVID gene therapy injections are effective, Prozac was originally assessed to treat obesity, but was switched for depression which has a subjective metric which was easier to approve with doctored studies (after which they pivoted to using marketing off-label for obesity). “So, even though the evidence showing Prozac worked for depression was atrocious while abundant evidence existed for its harm, with a few well priced bribes and statistical creativity, Eli-Lilly was able to secure their approval.”  Sound familiar?
  • Government corruption has followed a playbook that existed long before the COVID debacle
  • While the COVID injections have complete legal immunity, SSRIs are toxic enough to have severely harmed large numbers of people motivated to fight the drug companies in court
  • The author states he was able to accurately predict and understand the COVID shot shenanigans due to being intimately familiar with the SSRI story.

Category:

Activism, Psychological Aspects, Treatment

Novel Therapy Destroys Lyme in Lab

https://projectlyme.org/novel-therapy-destroys-lyme-in-lab/

Novel Therapy Destroys Lyme In Lab

Research Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests

Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases. This project was partially funded by Project Lyme, in partnership with the Bay Area Lyme Foundation. Learn more about our funded research here.

http://

Dr. Neil Spector Research Project

Nov. 1, 2023

PORTOLA VALLEY, Calif. November 1, 2023 – Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the development of a potential new drug, HS-291, that targets and destroys Borrelia burgdorferi, the bacterium that causes Lyme disease. Published in the peer-reviewed journal Cell Chemical Biology, this laboratory study represents a novel paradigm shift for anti-microbial treatment research as it is the first to target and inhibit Borrelia burgdorferi HtpG (high-temperature protein G), a specific type of enzyme within the bacteria that causes Lyme disease— a condition affecting nearly 500,000 new patients annually. The research was conducted at Duke University School of Medicine, with collaboration from the University of North Carolina, Tulane University, and Stanford University, and HS-291 is currently in preclinical stage testing at UC Davis.

“As Lyme disease is currently treated with broad-spectrum antibiotics and there are no targeted treatments, we are particularly excited about this discovery, and hopeful that our novel Lyme disease therapeutic HS-291 will specifically destroy the Lyme bacterium without off-target effects or antibiotic resistance,” said Timothy Haystead, PhD, professor of Pharmacology and Cancer Biology, Duke University School of Medicine, Bay Area Lyme Foundation grantee, and co-lead author. “This research has been an incredible opportunity to leverage knowledge from oncology to Lyme disease to design an investigational therapeutic that could one day benefit hundreds of thousands of patients with Lyme.”

This discovery has implications beyond Lyme disease as it demonstrates that using the drug HS-291 to deliver cellular toxins to HtpG, a type of non-essential enzyme that assists the folding or unfolding of large and complex proteins, greatly expands what can be considered druggable within any pathogen and opens a whole new area of infectious disease research.

When activated, HS-291, an inhibitor of HtpG tethered to the photoactive cellular toxin verteporfin, causes discrete protein modifications, which wreaks havoc on the Lyme disease bacterium’s DNA. This impacts multiple processes including nucleoid collapse and cell wall disruptions. A single dose of HS-291, when activated by light, irreversibly damages Borrelia proteins in close proximity of Bb HtpG in vitro.

“Antibiotics used to treat Lyme disease do not always work for all patients, which causes many to suffer for years with extreme symptoms including neurocognitive issues, disabling fatigue and sleep disruption,” said Linda Giampa, executive director of the Bay Area Lyme Foundation. “Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine. We hope that this discovery will inspire others to join us in investing in impactful, translational research to bring relief to patients.”

This research was made possible by a 2020 Bay Area Lyme Foundation grant of more than $2 million to Duke University School of Medicine in honor of Neil Spector, MD, a renowned oncologist who passed away from complications of Lyme disease that had been misdiagnosed for years. He encouraged scientists to take cancer staging techniques and immunotherapy learnings from oncology and apply them to Lyme research. Dr. Spector was the Sandra Coates associate professor in the Duke University Department of Medicine and also served on Bay Area Lyme Foundation’s Scientific Advisory Board.

Haystead and Spector joined forces as Spector sought to leverage his knowledge of oncology to help better understand Lyme disease, and Haystead’s research is focused on the use of chemical biology approaches to define novel drug targets focused on the treatment of hypertension, obesity, cancer, inflammatory and infectious disease.

Bay Area Lyme Foundation also funded University of North Carolina collaborator, Matt Redinbo, PhD’s research on HS-291; his lab’s crystallography work was instrumental in the discovery process.

Bay Area Lyme Foundation’s research grant program was made possible by the support from the Fairbairn Family, the Younger Family Fund, and Project Lyme.

For more:

Category:

Lyme, research, Treatment